news on tirzepatide drug fast-tracked for weight loss indication by FDA: What to know about it when was tirzepatide approved https://investor.lilly.com/news-releases/news-release-details/zepbound-

Excessive growth hormone can lead to side effects such as joint pain, swelling, insulin resistance, and injection site reactions

Ideally, patients who use this medication as a form of obesity management will accompany their weight loss with a significant lifestyle change and participate in a weight loss management program with their doctor or a nutritionist

This pathway signals through Gq-phospholipase C-IP3 cascades, increasing intracellular calcium and promoting GH vesicle exocytosis

There has been significant research in recent years focused on the other potential benefits of GLP-1 analogues, many of which could be due to the impact they have on body mass index (BMI) and obesity